The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Hantson Ludwig since year 2005.
The trader's CIK number is 1491435.
At the time of this reporting, Hantson Ludwig is the CEO of Alexion Pharmaceuticals, Inc. .
(stock ticker symbol ALXN).
See this page for all insider trading activities at Alexion Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-31||ALXN||Alexion Pharmaceuticals, Inc.||Sale||3,244||95.85||310,937|
|2018-02-08||ALXN||Alexion Pharmaceuticals, Inc.||Sale||13,245||116.31||1,540,525|
|2018-01-02||ALXN||Alexion Pharmaceuticals, Inc.||Sale||2,553||121.63||310,521|
|2017-06-14||ALXN||Alexion Pharmaceuticals, Inc.||Buy||10,000||116.72||1,167,200|
|2014-07-09||BAX||Baxter International Inc||Sale||24,693||76.00||1,876,668|
|2014-07-09||BAX||Baxter International Inc||Option Ex||18,030||41.54||748,966|
|2013-01-28||BAX||Baxter International Inc||Sale||10,500||67.64||710,220|
|2012-09-25||BAX||Baxter International Inc||Sale||36,059||61.54||2,219,070|
|2012-09-25||BAX||Baxter International Inc||Option Ex||36,059||41.54||1,497,890|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hantson Ludwig (CEO of Alexion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.